Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2026 May 29;82(Pt 6):751–754. doi: 10.1107/S2056989026004895

Crystal structure of (3R,5aS,6R,9R,12R,12aR)-3,6,9-tri­methyl­deca­hydro-12H-3,12-ep­oxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexa­hydro-1H-thieno[3,4-d]imidazol-4-yl)penta­noate

Xiaomei Yang a, Siyu Chen b, Wenxin Liu a, Mengjie Cui a, Qingjie Zhao a,*
Editor: W T A Harrisonc
PMCID: PMC13239019  PMID: 42254776

In the title biotin-conjugated di­hydro­artemisinin (DHA) derivative, the mol­ecule retains the essential endoperoxide bridge and links the C-10 position of DHA to the penta­noate chain of biotin via an ester bond. This structure determination provides a valuable blueprint for the rational design of hybrid anti­malarial and anti­cancer therapies based on DHA–biotin conjugates.

Keywords: crystal structure, di­hydro­artemisinin, biotin conjugate, endoperoxide bridge, anti­tumor activity

Abstract

In the title biotin-conjugated di­hydro­artemisinin (DHA) derivative, C25H38N2O7S, the mol­ecule retains the essential endoperoxide bridge and links the C-10 position of DHA to the penta­noate chain of biotin via an ester bond. In the solid state, the tetra­hydro­pyran ring of DHA adopts a chair conformation, the fused peroxide seven-membered ring exhibits a twist conformation, the imidazolidone ring of biotin shows an envelope conformation and the tetra­hydro­thio­phene ring adopts a twisted conformation. Supra­molecularly, adjacent mol­ecules are linked through a classical N—H⋯O double hydrogen-bonding motif between the urea groups of biotin, forming anti­parallel cyclic dimers. These strong dimers are further supported by weaker C—H⋯O inter­actions. The SQUEEZE [Spek (2015 ▸). Acta Cryst. C71, 9-18] routine in PLATON was used to remove electron density corresponding to disordered solvent mol­ecules. This structure determination provides a valuable blueprint for the rational design of hybrid anti­malarial and anti­cancer therapies based on DHA–biotin conjugates.

1. Chemical context

Artemisinin (C15H22O5; ART), isolated from Artemisia annua, and its active metabolite di­hydro­artemisinin (C15H24O5; DHA) are cornerstone anti­malarial agents, particularly effective against drug-resistant Plasmodium falciparum strains. Their pharmacological significance extends to oncology, where DHA exhibits potent anti­tumor activity across various cancers, including breast, lung, and melanoma, by inhibiting angiogenesis, inducing apoptosis, and promoting ferroptosis through iron-dependent reactive oxygen species (ROS) generation. The endoperoxide bridge in ART and DHA is crucial for cytotoxicity. In the presence of ferrous iron, this moiety undergoes homolytic cleavage, yielding carbon-centered radicals that alkyl­ate biomacromolecules and trigger oxidative stress, leading to parasite and cancer cell death. Derivatives lacking this bridge, such as de­oxy­artemisinin, show markedly reduced potency, underscoring its essential role.

Conjugating DHA with biotin – a vitamin overexpressed on tumor cells via specific transporters – offers significant biological advantages. Biotinylation enhances tumor targeting, improves cellular uptake, and enables avidin-mediated delivery systems, boosting efficacy while minimizing off-target effects, as demonstrated in biotin-ART micelle formulations that reduced tumor volumes in breast cancer models.1.

As part of our studies in this area, we now report the synthesis and single-crystal structure of the title biotin-conjugated DHA derivative, C26H40N2O6S (I). This polycyclic scaffold preserves the peroxide bridge while linking DHA’s C-10 atom to biotin’s penta­noate chain, potentially optimizing pharmacokinetics and selectivity.

2. Structural commentary

The crystal of (I) belongs to the monoclinic system, space group P21, with Z = 2, containing one complete mol­ecule in the asymmetric unit (Fig. 1 ▸). Mol­ecule (I) consists of a di­hydro­artemisinin (DHA) core linked to a biotin side chain through an ester bond. The DHA moiety retains its natural absolute configuration of (3R, 5aS, 6R, 9R, 12R, 12aR), while the biotin moiety adopts a (3aS, 4S, 6aR) configuration. Key bond lengths are as follows: the per­oxy bridge O1—O2 separation is 1.462 (4) Å, the ester C10—O5 bond is 1.416 (4) Å, and the carbonyl C16=O6 bond is 1.206 (5) Å, all within normal ranges. The crucial O5—C10—O4 bond angle measures 104.3 (3)°. Four representative torsion angles are C1—O1—O2—C12 = 46.5 (4), C8—C9—C10—O5 = 178.5 (3), C11—O4—C10—O5 = 1778.0 (3) and C15—C9—C10—O5 = −56.8 (5)°. The tetra­hydro­pyran (C4–C8/C12) ring in the DHA core adopts a stable chair conformation, while the fused peroxide and seven-membered ring (C1–C4/C12/C11/O3) exhibits a twist conformation. The imidazolidone ring in the biotin unit (N1/C24/C23/N2/C25) displays an envelope conformation, and the tetra­hydro­thio­phene ring (S1/C21/C24/C23/C22) shows a twisted conformation. The overall stereochemistry of the mol­ecule agrees with the expected configuration, and formation of the ester linkage does not introduce any significant conformational distortion.

Figure 1.

Figure 1

The mol­ecular structure of (I) showing 50% probability ellipsoids.

3. Supra­molecular features

The extended structure of (I) (Fig. 2 ▸) exhibits a well-defined hydrogen-bonded network dominated by strong N—H⋯O inter­actions between the urea groups of the biotin moieties. These classical amide–urea dimers adopt the characteristic DADA double hydrogen-bond motif (Table 1 ▸), a supra­molecular feature commonly observed in biotin and its derivatives: the N1—H1⋯O7 and N2—H2⋯O7 bonds together link adjacent mol­ecules through a pair of nearly linear N—H⋯O hydrogen bonds to generate cyclic dimeric units. Each dimer is stabilized by the anti­parallel orientation of the biotin urea fragments, resulting in a robust ring-like supra­molecular motif.

Figure 2.

Figure 2

The packing of (I) viewed along the b-axis direction. Dashed lines indicate C—H⋯O and N—H⋯O hydrogen bonds between adjacent mol­ecules, illustrating the hydrogen-bonded three-dimensional supra­molecular assembly network and the unit-cell arrangement.

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A D⋯A D—H⋯A
N1—H1⋯O7i 0.88 2.16 3.004 (4) 162
N2—H2⋯O7ii 0.88 2.07 2.886 (5) 154
C13—H13A⋯O7iii 0.98 2.63 3.438 (6) 140
C17—H17A⋯O2iv 0.99 2.44 3.431 (5) 178
C24—H24⋯O3v 1.00 2.44 3.204 (5) 133

Symmetry codes: (i) Inline graphic; (ii) Inline graphic; (iii) Inline graphic; (iv) Inline graphic; (v) Inline graphic.

In addition to these dominant inter­actions, several weaker C—H⋯O hydrogen bonds further consolidate the crystal packing and help maintain the conformation of the di­hydro­artemisinin (DHA) unit and its ester side chain. Notably, a C13—H13A⋯O7 contact connects a methyl group of the DHA moiety with the carbonyl oxygen atom of the biotin fragment. A nearly linear (178°) C17—H17A⋯O2 inter­action links the methyl­ene group of the linker region to a peroxide oxygen atom within the DHA core, while C24—H24⋯O3 connects the tetra­hydro­thio­phene ring of biotin to an ether oxygen atom of the DHA framework.

These N—H⋯O and C—H⋯O inter­actions inter­link the mol­ecules along the crystallographic b-axis through the 21 screw axis, giving rise to a three-dimensional supra­molecular network. Overall, the supra­molecular architecture is primarily governed by the strong dimeric hydrogen bonds between urea groups, complemented by auxiliary C—H⋯O contacts that anchor the flexible DHA skeleton within the lattice while preserving the classical self-recognition mode characteristic of biotin-based systems.

4. Database survey

A search of the Cambridge Structural Database (CSD) via the WebCSD inter­face (CSD version 2025.1, May 2025 release; Groom et al., 2016 ▸) for artemisinin-related structures returned 23 hits, predominantly consisting of artemisinin, di­hydro­artemisinin (DHA), artemether, artesunate and their derivatives. Key entries include the parent artemisinin structure with CSD refcode QINGHA (Liu et al., 1979 ▸; Qinghaosu Research Group, 1980 ▸), which confirmed the absolute configuration and endoperoxide bridge essential for anti­malarial activity. The α/β-di­hydro­artemisinin ether dimer YIGGEC (Yue et al., 2006 ▸) and the 7β-hy­droxy­artemisinin derivative GEMBET (Carvalho et al., 2008 ▸) represent metabolically modified analogs generated via microbial transformation. Other notable entries comprise a multicomponent crystal of artesunate with urea aceto­nitrile solvate (CCDC 1590278; Jiang et al., 2020 ▸), illustrating the use of cinchona alkaloids to form multicomponent crystals with artesunate. A trioxane azido derivative LALBON (Xie et al., 2010 ▸) retains the endoperoxide and exhibits weak C—H⋯N/O inter­actions in the solid state. The ferrous bromide rearrangement product of a 5β-hy­droxy-d-secoartemisinin analog (LALBOT; Jahan et al., 2021 ▸) and the corresponding Mosher ester derivative (CCDC 2006194; Jahan et al., 2021 ▸) provide insight into iron-mediated degradation pathways relevant to the mechanism of action. A search for biotin-related small mol­ecules gave 19 hits, including d-biotin (BIOTIN; DeTitta et al., 1976 ▸), de­thio­biotin (DETHIO10; DeTitta & Edmonds, 1980 ▸) and various biotin ester derivatives (e.g., BIWYEA; Blauż et al., 2016 ▸). A substructure search for a covalent conjugate featuring both an artemisinin-derived endoperoxide moiety and a biotin-derived ureido­tetra­hydro­thieno[3,4-d]imidazole scaffold linked via an ester bond, however, returned zero hits. This finding establishes the structural novelty of the present DHA–biotin ester conjugate, whose single-crystal X-ray analysis confirms the retention of the endoperoxide bridge [O1—O2 = 1.462 (4) Å] and the classical N—H⋯O dimeric hydrogen-bonding motif between biotin urea groups, as previously observed in avidin–biotin recognition (Livnah et al., 1993 ▸) and in ferrocene–biotin conjugates (Blauż et al., 2016 ▸).

5. Synthesis and crystallization

To a solution of biotin (1.0 equiv) and di­hydro­artemisinin (1.1 equiv) in anhydrous di­methyl­formamide (DMF; 2 ml) were added 1-ethyl-3-(3-di­methyl­amino­prop­yl)carbodi­imide (EDC) (3.0 equiv) and 4-di­methyl­amino­pyridine (DMAP) (1.0 equiv) (Fig. 3 ▸) at room temperature under nitro­gen atmosphere. The reaction proceeded smoothly for 2 h to afford the title compound in a yield of 78% (Fig. 3 ▸).

Figure 3.

Figure 3

Reaction scheme for obtaining the title compound.

The compound with a purity of over 98% was dissolved in petroleum ether, then left to stand while the solvent was allowed to evaporate gradually under controlled conditions to form colorless needles of (I).

6. Refinement

Crystal data, data collection and structure refinement details are summarized in Table 2 ▸. There were severely disordered solvent mol­ecules (likely petroleum ether or DMF) in the structure that could not be modeled effectively. Therefore, the SQUEEZE routine (Spek, 2015 ▸) in PLATON was used to remove the corresponding electron density. The calculated mol­ecular weight and density do not include the contribution of these squeezed solvents.

Table 2. Experimental details.

Crystal data
Chemical formula C25H38N2O7S
M r 510.63
Crystal system, space group Monoclinic, P21
Temperature (K) 150
a, b, c (Å) 12.8909 (8), 7.5857 (4), 14.9027 (9)
β (°) 103.924 (4)
V (Å3) 1414.46 (15)
Z 2
Radiation type Cu Kα
μ (mm−1) 1.37
Crystal size (mm) 0.08 × 0.03 × 0.01
 
Data collection
Diffractometer Bruker D8 VENTURE DUO PHOTON III
Absorption correction Multi-scan (SADABS; Krause et al., 2015 ▸)
Tmin, Tmax 0.90, 0.99
No. of measured, independent and observed [I > 2σ(I)] reflections 16792, 4678, 3874
R int 0.059
(sin θ/λ)max (Å−1) 0.597
 
Refinement
R[F2 > 2σ(F2)], wR(F2), S 0.044, 0.123, 1.02
No. of reflections 4678
No. of parameters 320
No. of restraints 1
H-atom treatment H-atom parameters constrained
Δρmax, Δρmin (e Å−3) 0.25, −0.23
Absolute structure Flack x determined using 1374 quotients [(I+)−(I−)]/[(I+)+(I−)] (Parsons et al., 2013 ▸)
Absolute structure parameter 0.034 (14)

Computer programs: APEX4 and SAINT (Bruker, 2021 ▸), SHELXT2018/2 (Sheldrick, 2015a ▸), SHELXL2018/3 (Sheldrick, 2015b ▸) and OLEX2 (Dolomanov et al., 2009 ▸).

Supplementary Material

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S2056989026004895/hb8220sup1.cif

e-82-00751-sup1.cif (617.5KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989026004895/hb8220Isup2.hkl

e-82-00751-Isup2.hkl (372.4KB, hkl)

CCDC reference: 2553196

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

The authors are grateful to the Single Crystal Diffraction Facility of Shanghai University for providing the X-ray data. We also acknowledge the Cambridge Crystallographic Data Centre (CCDC) for access to the Cambridge Structural Database and related resources.

supplementary crystallographic information

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Crystal data

C25H38N2O7S F(000) = 548
Mr = 510.63 Dx = 1.199 Mg m−3
Monoclinic, P21 Cu Kα radiation, λ = 1.54178 Å
a = 12.8909 (8) Å Cell parameters from 4632 reflections
b = 7.5857 (4) Å θ = 3.1–66.7°
c = 14.9027 (9) Å µ = 1.37 mm−1
β = 103.924 (4)° T = 150 K
V = 1414.46 (15) Å3 Needle, colorless
Z = 2 0.08 × 0.03 × 0.01 mm

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Data collection

Bruker D8 VENTURE DUO PHOTON III diffractometer 3874 reflections with I > 2σ(I)
ω scans Rint = 0.059
Absorption correction: multi-scan (SADABS; Krause et al., 2015) θmax = 66.9°, θmin = 3.1°
Tmin = 0.90, Tmax = 0.99 h = −15→15
16792 measured reflections k = −7→9
4678 independent reflections l = −17→17

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Refinement

Refinement on F2 H-atom parameters constrained
Least-squares matrix: full w = 1/[σ2(Fo2) + (0.0757P)2] where P = (Fo2 + 2Fc2)/3
R[F2 > 2σ(F2)] = 0.044 (Δ/σ)max = 0.005
wR(F2) = 0.123 Δρmax = 0.25 e Å−3
S = 1.02 Δρmin = −0.23 e Å−3
4678 reflections Extinction correction: SHELXL-2018/3 (Sheldrick 2015b), Fc*=kFc[1+0.001xFc2λ3/sin(2θ)]-1/4
320 parameters Extinction coefficient: 0.0052 (9)
1 restraint Absolute structure: Flack x determined using 1374 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Hydrogen site location: inferred from neighbouring sites Absolute structure parameter: 0.034 (14)

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Special details

Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
S1 0.20915 (8) 0.91961 (15) 0.81646 (8) 0.0505 (3)
O1 0.3657 (2) −0.0313 (4) 0.2718 (2) 0.0458 (7)
O2 0.44866 (19) 0.0792 (4) 0.24888 (19) 0.0404 (6)
O3 0.2270 (2) 0.1621 (4) 0.2161 (2) 0.0456 (7)
O4 0.3154 (2) 0.2950 (4) 0.34723 (19) 0.0462 (7)
O5 0.3909 (2) 0.4090 (4) 0.48693 (18) 0.0468 (7)
O6 0.2471 (3) 0.5877 (5) 0.4587 (2) 0.0628 (9)
O7 −0.0070 (2) 0.9020 (4) 1.02806 (17) 0.0454 (6)
N1 0.0146 (3) 0.7662 (4) 0.8946 (2) 0.0361 (7)
H1 0.027671 0.658762 0.916697 0.043*
N2 −0.0131 (3) 1.0527 (5) 0.8929 (2) 0.0489 (9)
H2 −0.029146 1.156896 0.911758 0.059*
C1 0.2702 (3) −0.0056 (6) 0.2019 (3) 0.0472 (10)
C2 0.2875 (4) −0.0182 (6) 0.1046 (3) 0.0568 (12)
H2A 0.224701 −0.076423 0.064125 0.068*
H2B 0.350640 −0.093609 0.106140 0.068*
C3 0.3047 (4) 0.1613 (7) 0.0624 (3) 0.0530 (11)
H3A 0.316922 0.140743 0.000095 0.064*
H3B 0.238135 0.230865 0.054350 0.064*
C4 0.3979 (3) 0.2722 (6) 0.1184 (3) 0.0440 (10)
H4 0.464604 0.220533 0.106201 0.053*
C5 0.3932 (3) 0.4658 (6) 0.0846 (3) 0.0487 (11)
H5 0.328070 0.521826 0.097374 0.058*
C6 0.4891 (4) 0.5656 (7) 0.1371 (3) 0.0568 (12)
H6A 0.484468 0.689124 0.115031 0.068*
H6B 0.554409 0.512710 0.124660 0.068*
C7 0.4980 (4) 0.5642 (6) 0.2411 (3) 0.0520 (11)
H7A 0.435923 0.627083 0.254181 0.062*
H7B 0.563545 0.627881 0.272931 0.062*
C8 0.5017 (3) 0.3759 (5) 0.2794 (3) 0.0416 (9)
H8 0.570105 0.322268 0.272309 0.050*
C9 0.5033 (3) 0.3668 (5) 0.3833 (3) 0.0428 (9)
H9 0.515695 0.241411 0.403753 0.051*
C10 0.3938 (3) 0.4198 (6) 0.3927 (2) 0.0425 (8)
H10 0.375336 0.541369 0.368037 0.051*
C11 0.3043 (3) 0.2912 (6) 0.2501 (3) 0.0386 (8)
H11 0.275535 0.407766 0.224163 0.046*
C12 0.4096 (3) 0.2584 (5) 0.2232 (3) 0.0375 (9)
C13 0.1948 (4) −0.1446 (7) 0.2248 (4) 0.0644 (14)
H13A 0.120870 −0.113683 0.194582 0.097*
H13B 0.203215 −0.149263 0.291871 0.097*
H13C 0.212073 −0.260022 0.202622 0.097*
C14 0.3851 (4) 0.4786 (8) −0.0199 (3) 0.0702 (15)
H14A 0.386812 0.602762 −0.037677 0.105*
H14B 0.317880 0.425094 −0.053913 0.105*
H14C 0.445360 0.416090 −0.034798 0.105*
C15 0.5923 (4) 0.4794 (7) 0.4432 (3) 0.0559 (11)
H15A 0.597680 0.453881 0.508621 0.084*
H15B 0.575689 0.604524 0.431167 0.084*
H15C 0.660379 0.451758 0.428080 0.084*
C16 0.3104 (3) 0.4963 (6) 0.5113 (3) 0.0464 (10)
C17 0.3106 (3) 0.4587 (6) 0.6095 (3) 0.0458 (10)
H17A 0.380400 0.495470 0.649024 0.055*
H17B 0.304132 0.329780 0.616797 0.055*
C18 0.2231 (3) 0.5482 (6) 0.6440 (3) 0.0451 (10)
H18A 0.152821 0.501030 0.610520 0.054*
H18B 0.223951 0.676273 0.631481 0.054*
C19 0.2379 (3) 0.5181 (6) 0.7478 (3) 0.0429 (9)
H19A 0.300397 0.586948 0.781685 0.052*
H19B 0.253349 0.391870 0.761697 0.052*
C20 0.1395 (3) 0.5716 (5) 0.7824 (3) 0.0401 (9)
H20A 0.078893 0.494997 0.752409 0.048*
H20B 0.154677 0.550105 0.849798 0.048*
C21 0.1064 (3) 0.7618 (5) 0.7639 (3) 0.0390 (9)
H21 0.089365 0.780523 0.695482 0.047*
C22 0.1103 (4) 1.0931 (6) 0.7889 (4) 0.0540 (12)
H22A 0.132734 1.195311 0.830339 0.065*
H22B 0.102292 1.132618 0.724264 0.065*
C23 0.0041 (4) 1.0191 (6) 0.8017 (3) 0.0444 (10)
H23 −0.056977 1.065423 0.752700 0.053*
C24 0.0082 (3) 0.8141 (5) 0.7977 (3) 0.0369 (9)
H24 −0.058346 0.765882 0.755939 0.044*
C25 −0.0017 (3) 0.9048 (5) 0.9458 (3) 0.0370 (8)

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
S1 0.0525 (5) 0.0362 (6) 0.0686 (7) −0.0132 (5) 0.0258 (5) −0.0079 (5)
O1 0.0413 (13) 0.0288 (16) 0.0662 (17) −0.0034 (11) 0.0108 (12) 0.0005 (13)
O2 0.0362 (13) 0.0272 (14) 0.0578 (16) 0.0016 (11) 0.0111 (11) 0.0007 (12)
O3 0.0378 (14) 0.0413 (17) 0.0604 (18) 0.0028 (12) 0.0173 (12) −0.0038 (14)
O4 0.0519 (15) 0.0422 (17) 0.0504 (16) 0.0006 (13) 0.0237 (12) −0.0025 (13)
O5 0.0582 (15) 0.0404 (16) 0.0465 (14) 0.0076 (14) 0.0217 (12) −0.0016 (14)
O6 0.082 (2) 0.060 (2) 0.0547 (18) 0.0288 (19) 0.0323 (16) 0.0079 (17)
O7 0.0724 (17) 0.0240 (14) 0.0471 (15) 0.0008 (13) 0.0285 (12) 0.0000 (13)
N1 0.0512 (18) 0.0223 (17) 0.0400 (18) −0.0007 (13) 0.0209 (14) −0.0019 (13)
N2 0.084 (3) 0.0252 (19) 0.046 (2) 0.0104 (17) 0.0325 (18) 0.0021 (15)
C1 0.041 (2) 0.034 (2) 0.065 (3) 0.0002 (17) 0.0097 (18) −0.004 (2)
C2 0.061 (3) 0.047 (3) 0.060 (3) −0.003 (2) 0.010 (2) −0.019 (2)
C3 0.055 (3) 0.056 (3) 0.048 (3) 0.006 (2) 0.011 (2) −0.008 (2)
C4 0.048 (2) 0.046 (3) 0.041 (2) 0.0097 (18) 0.0172 (17) 0.0022 (19)
C5 0.053 (2) 0.049 (3) 0.049 (2) 0.010 (2) 0.0221 (18) 0.009 (2)
C6 0.059 (3) 0.046 (3) 0.073 (3) 0.005 (2) 0.030 (2) 0.019 (2)
C7 0.061 (3) 0.037 (3) 0.060 (3) −0.007 (2) 0.019 (2) 0.001 (2)
C8 0.043 (2) 0.034 (2) 0.049 (2) 0.0002 (16) 0.0148 (16) −0.0025 (18)
C9 0.049 (2) 0.030 (2) 0.050 (2) 0.0015 (16) 0.0136 (17) −0.0067 (17)
C10 0.057 (2) 0.034 (2) 0.0408 (19) −0.002 (2) 0.0212 (16) −0.0039 (19)
C11 0.0414 (19) 0.033 (2) 0.044 (2) 0.0050 (16) 0.0163 (16) −0.0003 (17)
C12 0.043 (2) 0.028 (2) 0.044 (2) 0.0053 (15) 0.0142 (16) −0.0028 (16)
C13 0.053 (3) 0.045 (3) 0.091 (4) −0.010 (2) 0.010 (2) −0.001 (3)
C14 0.085 (3) 0.076 (4) 0.056 (3) 0.014 (3) 0.030 (2) 0.024 (3)
C15 0.060 (2) 0.053 (3) 0.056 (2) −0.008 (2) 0.016 (2) −0.013 (2)
C16 0.056 (2) 0.038 (2) 0.051 (2) 0.012 (2) 0.0242 (19) 0.004 (2)
C17 0.054 (2) 0.041 (3) 0.045 (2) 0.0073 (19) 0.0180 (17) 0.0006 (19)
C18 0.055 (2) 0.041 (2) 0.044 (2) 0.0058 (19) 0.0212 (18) −0.0022 (19)
C19 0.053 (2) 0.034 (2) 0.047 (2) 0.0064 (17) 0.0240 (17) 0.0061 (18)
C20 0.051 (2) 0.028 (2) 0.048 (2) 0.0020 (17) 0.0229 (17) −0.0004 (17)
C21 0.047 (2) 0.027 (2) 0.048 (2) −0.0009 (16) 0.0225 (17) −0.0023 (17)
C22 0.083 (3) 0.025 (2) 0.066 (3) −0.001 (2) 0.040 (2) 0.000 (2)
C23 0.065 (3) 0.035 (2) 0.040 (2) 0.0116 (19) 0.0246 (19) 0.0032 (18)
C24 0.043 (2) 0.032 (2) 0.040 (2) 0.0000 (16) 0.0181 (17) −0.0012 (17)
C25 0.0449 (18) 0.024 (2) 0.046 (2) 0.0011 (16) 0.0177 (15) 0.0004 (18)

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Geometric parameters (Å, º)

S1—C21 1.817 (4) C8—H8 1.0000
S1—C22 1.809 (5) C8—C9 1.545 (6)
O1—O2 1.462 (4) C8—C12 1.558 (5)
O1—C1 1.422 (5) C9—H9 1.0000
O2—C12 1.468 (5) C9—C10 1.506 (5)
O3—C1 1.425 (5) C9—C15 1.533 (6)
O3—C11 1.402 (5) C10—H10 1.0000
O4—C10 1.431 (5) C11—H11 1.0000
O4—C11 1.420 (5) C11—C12 1.525 (5)
O5—C10 1.416 (4) C13—H13A 0.9800
O5—C16 1.351 (5) C13—H13B 0.9800
O6—C16 1.206 (5) C13—H13C 0.9800
O7—C25 1.245 (4) C14—H14A 0.9800
N1—H1 0.8800 C14—H14B 0.9800
N1—C24 1.473 (5) C14—H14C 0.9800
N1—C25 1.344 (5) C15—H15A 0.9800
N2—H2 0.8800 C15—H15B 0.9800
N2—C23 1.452 (5) C15—H15C 0.9800
N2—C25 1.358 (5) C16—C17 1.490 (6)
C1—C2 1.522 (6) C17—H17A 0.9900
C1—C13 1.527 (6) C17—H17B 0.9900
C2—H2A 0.9900 C17—C18 1.509 (5)
C2—H2B 0.9900 C18—H18A 0.9900
C2—C3 1.538 (7) C18—H18B 0.9900
C3—H3A 0.9900 C18—C19 1.529 (5)
C3—H3B 0.9900 C19—H19A 0.9900
C3—C4 1.538 (6) C19—H19B 0.9900
C4—H4 1.0000 C19—C20 1.534 (5)
C4—C5 1.549 (7) C20—H20A 0.9900
C4—C12 1.537 (5) C20—H20B 0.9900
C5—H5 1.0000 C20—C21 1.511 (6)
C5—C6 1.499 (7) C21—H21 1.0000
C5—C14 1.539 (6) C21—C24 1.522 (5)
C6—H6A 0.9900 C22—H22A 0.9900
C6—H6B 0.9900 C22—H22B 0.9900
C6—C7 1.526 (6) C22—C23 1.533 (7)
C7—H7A 0.9900 C23—H23 1.0000
C7—H7B 0.9900 C23—C24 1.558 (5)
C7—C8 1.535 (6) C24—H24 1.0000
C22—S1—C21 88.9 (2) O2—C12—C4 105.7 (3)
C1—O1—O2 107.6 (3) O2—C12—C8 102.7 (3)
O1—O2—C12 111.5 (2) O2—C12—C11 110.7 (3)
C11—O3—C1 114.1 (3) C4—C12—C8 112.5 (3)
C11—O4—C10 112.5 (3) C11—C12—C4 112.4 (3)
C16—O5—C10 116.3 (3) C11—C12—C8 112.1 (3)
C24—N1—H1 123.7 C1—C13—H13A 109.5
C25—N1—H1 123.7 C1—C13—H13B 109.5
C25—N1—C24 112.6 (3) C1—C13—H13C 109.5
C23—N2—H2 123.9 H13A—C13—H13B 109.5
C25—N2—H2 123.9 H13A—C13—H13C 109.5
C25—N2—C23 112.2 (3) H13B—C13—H13C 109.5
O1—C1—O3 108.3 (3) C5—C14—H14A 109.5
O1—C1—C2 113.0 (3) C5—C14—H14B 109.5
O1—C1—C13 103.1 (4) C5—C14—H14C 109.5
O3—C1—C2 110.5 (4) H14A—C14—H14B 109.5
O3—C1—C13 106.9 (4) H14A—C14—H14C 109.5
C2—C1—C13 114.6 (4) H14B—C14—H14C 109.5
C1—C2—H2A 108.8 C9—C15—H15A 109.5
C1—C2—H2B 108.8 C9—C15—H15B 109.5
C1—C2—C3 113.8 (4) C9—C15—H15C 109.5
H2A—C2—H2B 107.7 H15A—C15—H15B 109.5
C3—C2—H2A 108.8 H15A—C15—H15C 109.5
C3—C2—H2B 108.8 H15B—C15—H15C 109.5
C2—C3—H3A 108.4 O5—C16—C17 110.5 (3)
C2—C3—H3B 108.4 O6—C16—O5 123.4 (4)
H3A—C3—H3B 107.4 O6—C16—C17 126.1 (4)
C4—C3—C2 115.6 (4) C16—C17—H17A 108.5
C4—C3—H3A 108.4 C16—C17—H17B 108.5
C4—C3—H3B 108.4 C16—C17—C18 115.1 (3)
C3—C4—H4 106.3 H17A—C17—H17B 107.5
C3—C4—C5 112.2 (3) C18—C17—H17A 108.5
C5—C4—H4 106.3 C18—C17—H17B 108.5
C12—C4—C3 112.8 (4) C17—C18—H18A 109.5
C12—C4—H4 106.3 C17—C18—H18B 109.5
C12—C4—C5 112.5 (3) C17—C18—C19 110.9 (3)
C4—C5—H5 108.1 H18A—C18—H18B 108.1
C6—C5—C4 110.3 (3) C19—C18—H18A 109.5
C6—C5—H5 108.1 C19—C18—H18B 109.5
C6—C5—C14 110.1 (4) C18—C19—H19A 109.0
C14—C5—C4 112.1 (4) C18—C19—H19B 109.0
C14—C5—H5 108.1 C18—C19—C20 112.8 (3)
C5—C6—H6A 109.2 H19A—C19—H19B 107.8
C5—C6—H6B 109.2 C20—C19—H19A 109.0
C5—C6—C7 112.2 (3) C20—C19—H19B 109.0
H6A—C6—H6B 107.9 C19—C20—H20A 108.7
C7—C6—H6A 109.2 C19—C20—H20B 108.7
C7—C6—H6B 109.2 H20A—C20—H20B 107.6
C6—C7—H7A 109.2 C21—C20—C19 114.3 (3)
C6—C7—H7B 109.2 C21—C20—H20A 108.7
C6—C7—C8 111.9 (4) C21—C20—H20B 108.7
H7A—C7—H7B 107.9 S1—C21—H21 107.7
C8—C7—H7A 109.2 C20—C21—S1 113.9 (3)
C8—C7—H7B 109.2 C20—C21—H21 107.7
C7—C8—H8 106.8 C20—C21—C24 114.2 (3)
C7—C8—C9 113.9 (3) C24—C21—S1 105.3 (3)
C7—C8—C12 112.4 (3) C24—C21—H21 107.7
C9—C8—H8 106.8 S1—C22—H22A 110.1
C9—C8—C12 109.8 (3) S1—C22—H22B 110.1
C12—C8—H8 106.8 H22A—C22—H22B 108.5
C8—C9—H9 108.1 C23—C22—S1 107.8 (3)
C10—C9—C8 107.1 (3) C23—C22—H22A 110.1
C10—C9—H9 108.1 C23—C22—H22B 110.1
C10—C9—C15 112.6 (3) N2—C23—C22 113.2 (4)
C15—C9—C8 112.7 (3) N2—C23—H23 110.5
C15—C9—H9 108.1 N2—C23—C24 103.0 (3)
O4—C10—C9 110.5 (3) C22—C23—H23 110.5
O4—C10—H10 110.9 C22—C23—C24 108.7 (4)
O5—C10—O4 104.3 (3) C24—C23—H23 110.5
O5—C10—C9 109.0 (3) N1—C24—C21 113.9 (3)
O5—C10—H10 110.9 N1—C24—C23 101.7 (3)
C9—C10—H10 110.9 N1—C24—H24 110.9
O3—C11—O4 105.7 (3) C21—C24—C23 108.1 (3)
O3—C11—H11 108.3 C21—C24—H24 110.9
O3—C11—C12 113.0 (3) C23—C24—H24 110.9
O4—C11—H11 108.3 O7—C25—N1 126.7 (4)
O4—C11—C12 113.1 (3) O7—C25—N2 124.2 (4)
C12—C11—H11 108.3 N1—C25—N2 109.1 (3)
S1—C21—C24—N1 −74.8 (4) C8—C9—C10—O4 64.4 (4)
S1—C21—C24—C23 37.4 (4) C8—C9—C10—O5 178.5 (3)
S1—C22—C23—N2 93.4 (4) C9—C8—C12—O2 −71.1 (4)
S1—C22—C23—C24 −20.5 (5) C9—C8—C12—C4 175.7 (3)
O1—O2—C12—C4 −108.2 (3) C9—C8—C12—C11 47.9 (4)
O1—O2—C12—C8 133.7 (3) C10—O4—C11—O3 179.0 (3)
O1—O2—C12—C11 13.8 (4) C10—O4—C11—C12 54.8 (4)
O1—C1—C2—C3 −95.4 (4) C10—O5—C16—O6 −4.2 (7)
O2—O1—C1—O3 −74.8 (3) C10—O5—C16—C17 174.2 (3)
O2—O1—C1—C2 47.9 (4) C11—O3—C1—O1 34.9 (4)
O2—O1—C1—C13 172.2 (3) C11—O3—C1—C2 −89.4 (4)
O3—C1—C2—C3 26.0 (5) C11—O3—C1—C13 145.3 (4)
O3—C11—C12—O2 −52.7 (4) C11—O4—C10—O5 178.0 (3)
O3—C11—C12—C4 65.3 (4) C11—O4—C10—C9 −64.9 (4)
O3—C11—C12—C8 −166.8 (3) C12—C4—C5—C6 55.2 (4)
O4—C11—C12—O2 67.4 (4) C12—C4—C5—C14 178.2 (3)
O4—C11—C12—C4 −174.6 (3) C12—C8—C9—C10 −55.7 (4)
O4—C11—C12—C8 −46.7 (4) C12—C8—C9—C15 179.9 (3)
O5—C16—C17—C18 −179.4 (4) C13—C1—C2—C3 146.9 (4)
O6—C16—C17—C18 −1.0 (7) C14—C5—C6—C7 177.3 (4)
N2—C23—C24—N1 −11.1 (4) C15—C9—C10—O4 −171.1 (3)
N2—C23—C24—C21 −131.4 (3) C15—C9—C10—O5 −57.0 (5)
C1—O1—O2—C12 46.5 (4) C16—O5—C10—O4 −79.5 (4)
C1—O3—C11—O4 −97.3 (4) C16—O5—C10—C9 162.5 (4)
C1—O3—C11—C12 26.9 (5) C16—C17—C18—C19 −173.5 (4)
C1—C2—C3—C4 56.9 (5) C17—C18—C19—C20 −167.7 (4)
C2—C3—C4—C5 −166.2 (3) C18—C19—C20—C21 −57.8 (5)
C2—C3—C4—C12 −38.0 (5) C19—C20—C21—S1 −59.4 (4)
C3—C4—C5—C6 −176.5 (3) C19—C20—C21—C24 179.6 (3)
C3—C4—C5—C14 −53.4 (5) C20—C21—C24—N1 50.8 (5)
C3—C4—C12—O2 70.6 (4) C20—C21—C24—C23 163.1 (4)
C3—C4—C12—C8 −178.1 (3) C21—S1—C22—C23 36.8 (3)
C3—C4—C12—C11 −50.4 (5) C22—S1—C21—C20 −168.9 (3)
C4—C5—C6—C7 −58.4 (5) C22—S1—C21—C24 −43.0 (3)
C5—C4—C12—O2 −161.4 (3) C22—C23—C24—N1 109.3 (4)
C5—C4—C12—C8 −50.0 (4) C22—C23—C24—C21 −10.9 (5)
C5—C4—C12—C11 77.7 (4) C23—N2—C25—O7 176.0 (4)
C5—C6—C7—C8 56.9 (5) C23—N2—C25—N1 −4.6 (5)
C6—C7—C8—C9 −176.3 (3) C24—N1—C25—O7 175.6 (3)
C6—C7—C8—C12 −50.6 (5) C24—N1—C25—N2 −3.7 (4)
C7—C8—C9—C10 71.4 (4) C25—N1—C24—C21 125.6 (4)
C7—C8—C9—C15 −53.0 (5) C25—N1—C24—C23 9.5 (4)
C7—C8—C12—O2 161.0 (3) C25—N2—C23—C22 −107.1 (4)
C7—C8—C12—C4 47.8 (4) C25—N2—C23—C24 10.2 (5)
C7—C8—C12—C11 −80.0 (4)

(3R,5aS,6R,9R,12R,12aR)-3,6,9-Trimethyldecahydro-12H-3,12-epoxy[1,2]dioxepino[4,3-i]isochromen-10-yl 5-((3aS,4S,6aR)-2-oxohexahydro-1H-thieno[3,4-d]imidazol-4-yl)pentanoate . Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
N1—H1···O7i 0.88 2.16 3.004 (4) 162
N2—H2···O7ii 0.88 2.07 2.886 (5) 154
C13—H13A···O7iii 0.98 2.63 3.438 (6) 140
C17—H17A···O2iv 0.99 2.44 3.431 (5) 178
C24—H24···O3v 1.00 2.44 3.204 (5) 133

Symmetry codes: (i) −x, y−1/2, −z+2; (ii) −x, y+1/2, −z+2; (iii) x, y−1, z−1; (iv) −x+1, y+1/2, −z+1; (v) −x, y+1/2, −z+1.

References

  1. Blauż, A., Rychlik, B., Makal, A., Szulc, K., Strzelczyk, P., Bujacz, G., Zakrzewski, J., Woźniak, K. & Plażuk, D. (2016). ChemPlusChem81, 1–13. [DOI] [PubMed]
  2. Bruker (2021). APEX4 and SAINT. Bruker AXS Inc., Madison, Wisconsin, USA.
  3. Carvalho, P. B., Liu, B., Wu, Y., Williamson, J. S. & Avery, M. A. (2008). Acta Cryst. E64, o395–o396. [DOI] [PMC free article] [PubMed]
  4. DeTitta, G. T. & Edmonds, J. W. (1980). J. Chem. Soc. Chem. Commun. pp. 1161–1162.
  5. DeTitta, G. T., Edmonds, J. W., Stallings, W. & Donohue, J. (1976). J. Am. Chem. Soc.98, 1920–1926. [DOI] [PubMed]
  6. Dolomanov, O. V., Bourhis, L. J., Gildea, R. J., Howard, J. A. K. & Puschmann, H. (2009). J. Appl. Cryst.42, 339–341.
  7. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  8. Jahan, M., Leon, F., Fronczek, F. R., Elokely, K. M., Rimoldi, J., Khan, S. I. & Avery, M. A. (2021). Molecules26, 4163. [DOI] [PMC free article] [PubMed]
  9. Jiang, Q., Hirsh, D. A., Tu, Y. & Luo, L. (2020). CrystEngComm22, 1234–1242.
  10. Krause, L., Herbst-Irmer, R., Sheldrick, G. M. & Stalke, D. (2015). J. Appl. Cryst.48, 3–10. [DOI] [PMC free article] [PubMed]
  11. Liu, J. M., Ni, M. Y., Fan, Y. E., Tu, Y. Y., Wu, Z. H., Wu, Y. L. & Chou, W. S. (1979). Acta Chim. Sinica37, 129–141.
  12. Livnah, O., Bayer, E. A., Wilchek, M. & Sussman, J. L. (1993). Proc. Natl Acad. Sci. USA90, 5076–5080. [DOI] [PMC free article] [PubMed]
  13. Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
  14. Qinghaosu Research Group (1980). Sci. Sin. (Engl. Ed.)23, 380–396.
  15. Sheldrick, G. M. (2015a). Acta Cryst. A71, 3–8.
  16. Sheldrick, G. M. (2015b). Acta Cryst. C71, 3–8.
  17. Spek, A. L. (2015). Acta Cryst. C71, 9–18. [DOI] [PubMed]
  18. Xie, L., Zhai, X., Zuo, J., Zhao, Y. & Gong, P. (2010). Acta Cryst. E66, o1839. [DOI] [PMC free article] [PubMed]
  19. Yue, Z.-Y., Li, S.-H., Gao, P., Zhang, J.-H. & Yan, P.-F. (2006). Acta Cryst. C62, o281–o282. [DOI] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) global, I. DOI: 10.1107/S2056989026004895/hb8220sup1.cif

e-82-00751-sup1.cif (617.5KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989026004895/hb8220Isup2.hkl

e-82-00751-Isup2.hkl (372.4KB, hkl)

CCDC reference: 2553196

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES